Table 2.
Clinical to pathologic staging changes
| Patient # | Clinical Stage at Baseline | Histology | Pathologic Stage |
|---|---|---|---|
|
| |||
| 2 | cT2 | UC | pT0N0 |
| 3 | cT2¥ | UC | pT0N0 |
| 4 | cT2¥ | UC | pT4aN0 |
| 5 | cT4a | UC | pT0N0 |
| 8 | cT3b, 3-D mass on EUA | UC with squamous differentiation | pT0N0 |
| 9 | cT2¥ | UC with plasmacytoid features | pT4N2 |
| 10 | cT2 | UC | pT1N0 |
| 11 | cT4a¥ | UC | pT1N0 |
| 12 | cT2¥ | UC with sarcomatoid features | pT0N0 |
| 13 | cT3b, 3-D mass on EUA | UC | pT2aN0 |
| 15 | cT3b, 3-D mass on EUA | UC | pTaN0 |
| 16 | cT3b, 3-D mass on EUA | UC | pT2N0 |
| 18 | cT2 | UC | pT3bN1 |
| 22 | cT2 | UC | pT2N0 |
| 23 | cT3b, 3-D mass on EUA | UC with squamous differentiation | pT0N0 |
| 24 | cT3b, 3-D mass on EUA | UC | pTisN0 |
| 25 | cT3b, 3-D mass on EUA | UC | pTis & TaN0 |
| 31 | cT2 | UC with focal micropapillary features | pT4aN2 |
| 32 | cT3b, 3-D mass on EUA | Small cell carcinoma | pT2N1 |
| 34 | cT2 | UC | pT2N0 |
| 35 | cT2¥ | UC | pT2N1 |
| 36 | cT3b, 3-D mass on EUA | UC | pT0N0 |
| 37 | cT1* | UC with focal micropapillary features | pT0N0 |
| 38 | cT3b | UC | pT1N0 |
*
cT1 with high grade histology, diffuse involvement of disease throughout the bladder and high-risk feature of micropapillary disease
¥
These patients had a second TURBT to further evaluate disease status prior to cystectomy
UC: urothelial carcinoma